Please login to the form below
LabCorp
This page shows the latest LabCorp news and features for those working in and with pharma, biotech and healthcare.
Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
The HARMONIE trial is part of a collaboration between Sanofi, the NIHR, investigators and the clinical research organisation, Labcorp.
Latest news
-
Clinical Researcher of the Year – The Americas 2021
involved! Labcorp Drug Development and PPD were also standouts on the night, taking home two Golds each.
-
V is for Verily: life sciences' new entry in Google's Alphabet
The new company's website says it will have four teams focusing on hardware, software, clinical and science, and will be headed by Andy Conrad, formerly chief scientific officer of LabCorp.
-
Is bigger always better in clinical outsourcing?
The rationale is to combine LabCorp's database of 70 million patient records with Covance's clinical services and overcome the longstanding issue of slow patient recruitment in clinical research. ... Critics have suggested that LabCorp's US focus makes
-
Covance and Sihuan Pharma partner on portfolio development
Will collaborate on preclinical and clinical stages. LabCorp's Covance and Shandon XuanZhu, a subsidiary of Chinese R&D firm Sihuan Pharmaceutical, have announced a partnership on preclinical and clinical portfolio ... LabCorp announced the acquisition
-
LabCorp to acquire Covance for $5.6bn
LabCorp chairman and CEO David P King and LabCorp chief financial officer Glenn Eisenberg will serve in the same positions for the combined company. ... Covance chairman and CEO Joe Herring will lead LabCorp's Covance division and report directly to King.
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2017
Also, the subject of rumours is LabCorp, the medical testing company which has money to spend.
-
Deal Watch July 2016
Cooper. Vemedia. $416m. $443m. 0.94x. N/A. LabCorp. Sequenom. $302. $128m. 2.4x. ... LabCorp has described its acquisition of Sequenom, which provides non-invasive prenatal testing, as strategic, and has paid $371m for the company.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
CROS NT appoints Renee Covell as head of US operation
Covell has 16 years of experience in the industry, including roles at LabCorp, Covance, Synteract and AAC Business Consulting, which she owns.
-
PPD appoints Dr David Johnston
He joins the CRO as executive vice president of global laboratory services after 16 years with medical laboratory firm LabCorp, where he was most recently senior vice president and global head
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
David P. King served for 13 years as chairman and CEO of LabCorp, where he spearheaded the company’s transformation from a pure-play clinical laboratory into a global leader in ... Today, LabCorp is a Fortune 250 company with over $15 billion in
-
Fishawack Health appoints new CEO, Jonathan Koch
He has spent his entire career in the healthcare sector, including nearly 12 years at Covance (now Labcorp Drug Development), serving last as Group President of Clinical Development and Commercialization services,
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Rare diseases: not so rare after all
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
PMHub
11 London
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
